Skip to main content
Postgraduate Medical Journal logoLink to Postgraduate Medical Journal
. 1982 Feb;58(676):82–84. doi: 10.1136/pgmj.58.676.82

Altered quinidine disposition in a patient with chronic active hepatitis

J Robert Powell, Kenneth A Conrad, Robert Okada, Theodor W Guentert, Sidney Riegelman
PMCID: PMC2426285  PMID: 7100030

Abstract

A 49-year-old female with chronic active hepatitis and ventricular ectopic activity was given i.v. 600 mg quindine gluconate (4·4 mg/kg). Quinidine plasma concentrations were analysed by high pressure liquid chromatography and plasma protein binding by equilibrium dialysis. The pharmacokinetic values were total body clearance 0·11 l/kg/hr, elimination half-life 41·5 hr, volume of the central compartment 2·26 l/kg, volume of distribution from the area under the curve 6·5 l/kg, and 19% unbound in plasma. Based on the limited information available, quinidine dosing should be markedly decreased in patients with severe liver dysfunction.

Full text

PDF
82

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Affrime M., Reidenberg M. M. The protein binding of some drugs in plasma from patients with alcoholic liver disease. Eur J Clin Pharmacol. 1975 Apr 4;8(3-4):267–269. doi: 10.1007/BF00567126. [DOI] [PubMed] [Google Scholar]
  2. Chien Y. W., Lambert H. J., Karim A. Comparative binding of disopyramide phosphate and quinidine sulfate to human plasma proteins. J Pharm Sci. 1974 Dec;63(12):1877–1879. doi: 10.1002/jps.2600631210. [DOI] [PubMed] [Google Scholar]
  3. Conrad K. A., Molk B. L., Chidsey C. A. Pharmacokinetic studies of quinidine in patients with arrhythmias. Circulation. 1977 Jan;55(1):1–7. [PubMed] [Google Scholar]
  4. Kates R. E., Sokoloski T. D., Comstock T. J. Binding of quinidine to plasma proteins in normal subjects and in patients with hyperlipoproteinemias. Clin Pharmacol Ther. 1978 Jan;23(1):30–35. doi: 10.1002/cpt197823130. [DOI] [PubMed] [Google Scholar]
  5. Pérez-Mateo M., Erill S. Protein binding of salicylate and quinidine in plasma from patients with renal failure, chronic liver disease and chronic respiratory insufficiency. Eur J Clin Pharmacol. 1977 Mar 11;11(3):225–231. doi: 10.1007/BF00606415. [DOI] [PubMed] [Google Scholar]
  6. Ueda C. T., Hirschfeld D. S., Scheinman M. M., Rowland M., Williamson B. J., Dzindzio B. S. Disposition kinetics of quinidine. Clin Pharmacol Ther. 1976 Jan;19(1):30–36. doi: 10.1002/cpt197619130. [DOI] [PubMed] [Google Scholar]

Articles from Postgraduate Medical Journal are provided here courtesy of BMJ Publishing Group

RESOURCES